NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.940
+0.050 (5.62%)
At close: Nov 6, 2024, 4:00 PM
0.960
+0.020 (2.13%)
Pre-market: Nov 7, 2024, 7:19 AM EST
Company Description
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.
It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.
It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator.
The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 16 |
| CEO | David Rosa |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 426 1383 |
| Website | n1mtc.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001500198 |
| CUSIP Number | 64130M209 |
| ISIN Number | US64130M2098 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer and Director |
| Ronald W. McClurg | Chief Financial Officer |
| Steven Mertens | Chief Technology Officer |
| Mark Christianson | Co-Founder, Business Development Director and Medical Sales Liaison |
| Christopher R. Volker CFA | Chief Operating Officer |
| Hijaz Haris | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 31, 2024 | 8-K | Current Report |
| Sep 13, 2024 | EFFECT | Notice of Effectiveness |
| Sep 13, 2024 | 8-K | Current Report |
| Sep 12, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Sep 5, 2024 | UPLOAD | Filing |
| Aug 30, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 16, 2024 | EFFECT | Notice of Effectiveness |
| Aug 16, 2024 | 424B5 | Filing |
| Aug 16, 2024 | D | Notice of Exempt Offering of Securities |
| Aug 14, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |